1. Home
  2. List
Reference Patent

Reference - List

  • 1,242 Hits
  • Search Condition : Filter (MeSH = Middle Aged)
Species Resource Title
Human and Animal Cells 293(RCB1637) Effects of Resmetirom on Resistance to Thyroid Hormone Receptor Mutants: Potential Basis for Therapeutic Applications.
Human and Animal Cells Lu-134-A(RCB0466) Characteristic miRNA profiles represent clinicopathological diversity of small cell lung cancer.
Human and Animal Cells LoVo(RCB1639) , HCT116(RCB2979) , CACO-2(RCB0988) Functional Analysis and Clinical Significance of Glutaredoxin 2 in Colon Cancer.
Human and Animal Cells TE-1(RCB1894) , TE-4(RCB2097) , TE-5(RCB1949) , TE-6(RCB1950) , TE-9(RCB1988) , TE-10(RCB2099) , TE-14(RCB2101) Cytotoxic Anti-tumor Drugs and Tumor-Associated Macrophages Synergistically Surge PD-L1 Expression in Esophageal Squamous Cell Carcinoma.
Human and Animal Cells Hep G2 , HuHー7 , AGS , MKN45 , BRE , TFK-1 , HCT116 Serum PKCδ is a useful biomarker to distinguish hepatocellular carcinoma from other gastrointestinal cancers.
Human and Animal Cells Ba/F3(RCB0805) Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation.
Human and Animal Cells TE-5(RCB1949) , TE-4(RCB2097) , TE-8(RCB2098) , TE-11(RCB2100) miR‑100‑5p and miR‑203a‑3p suppress esophageal squamous cell carcinoma progression by targeting FKBP5.
DNA material CSII-EF-MCS-IRES2-Venus (RDB04384) , pCSII-CLDN3 (RDB21016) , pCSII-CLDN5 (RDB21018) , pCSII-CLDN10A (RDB21023) , pCSII-CLDN12 (RDB21026) , pCSII-CLDN15 (RDB21027) Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer.
Human and Animal Cells HuH-7(RCB1366) Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma.
Human and Animal Cells TE-6(RCB1950) , TE-10(RCB2099) High expression of the cachexia-related protein Fn14 in esophageal squamous cell carcinoma correlates with poor chemotherapy response and anti-Fn14 therapy decreases chemotherapeutic resistance.
Human and Animal Cells TE-5(RCB1949) , TE-8(RCB2098) , TE-9(RCB1988) , TE-15(RCB1951) Low levels of tumor suppressor miR-3619 in plasma contribute to malignant outcomes and a target for nucleic acid therapy in esophageal cancer.
Human and Animal Cells TE-1(RCB1894) , TE-5(RCB1949) , TE-6(RCB1950) , TE-15(RCB1951) , TE-9(RCB1988) , TE-4(RCB2097) , TE-8(RCB2098) , TE-10(RCB2099) , TE-11(RCB2100) , TE-14(RCB2101) Activation of the tumor cell-intrinsic STING pathway induced by Fusobacterium nucleatum is associated with poor prognosis in esophageal cancer patients.
Human and Animal Cells 293T(RCB2202) BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis.
Zebrafish UAS:RFP Somatic Loss-of-Function PIK3R1 and Activating Non-hotspot PIK3CA Mutations Associated with Capillary Malformation with Dilated Veins (CMDV).
Human and Animal Cells SSP-25(RCB1293) Circulating galectin-9 as a novel prognosticator in patients with intrahepatic cholangiocarcinoma undergoing surgical resection.
Human pathogenic viruses DENV-1 , DENV-2 , DENV-3 , DENV-4 Impact of pre-existing cross-reactive antibodies on cyclic dengue outbreaks in the hyperendemic region of Bali, Indonesia.
Human pathogenic viruses DENV-1 , DENV-2 , DENV-3 Circulating serotypes and genotypes of dengue virus during the 2023 outbreak in Eastern Nepal.
Human pathogenic viruses DENV-1 , DENV-2 , DENV-3 , DENV-4 Molecular and Entomological Characterization of 2023 Dengue Outbreak in Dhading District, Central Nepal.
Human and Animal Cells TGBC1TKB(RCB1129) Unveiling the causative role of promoter variant rs113823671 in MMP7 in gallbladder cancer susceptibility.
Human and Animal Cells MKN7(RCB0999) , GSU(RCB2278) , NUGC-4(RCB1939) Real-time assessment of circulating tumor cells refines the indication for HER2-targeted therapy in metastatic gastric cancer.